<DOC>
	<DOCNO>NCT00546624</DOCNO>
	<brief_summary>This study determine effectiveness MK0777 GEM versus Lorazepam treatment patient generalize anxiety disorder . This early phase trial specific protocol information progress publicly available time . ( Full information available trial participant ) .</brief_summary>
	<brief_title>GEM 1.5 mg b.i.d . 4.5 mg b.i.d . Versus Lorazepam GAD ( 0777-026 )</brief_title>
	<detailed_description />
	<mesh_term>Anxiety Disorders</mesh_term>
	<criteria>Have diagnose Generalized Anxiety Disorder Women childbearing potential must use doublebarrier method contraception must negative blood pregnancy test begin study History drug alcohol abuse Have previously participate another study use MK0777</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>